| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: structure in first source
Also Known As:| 1. | Leiomyoma (Uterine Fibroids)
12/28/2000
- "The pharmacological properties of ZK 230211 may prove useful in the treatment of endometriosis, leiomyomas, breast cancer, and in hormone replacement therapy."
Order ALL the reference details at left... |
| 2. | Endometriosis (Adenomyosis)
12/28/2000
- "The pharmacological properties of ZK 230211 may prove useful in the treatment of endometriosis, leiomyomas, breast cancer, and in hormone replacement therapy."
Order ALL the reference details at left... |
| 3. | Breast Neoplasms (Breast Cancer)
12/28/2000
- "The pharmacological properties of ZK 230211 may prove useful in the treatment of endometriosis, leiomyomas, breast cancer, and in hormone replacement therapy."
Order ALL the reference details at left... |
| 4. | Neoplasms (Cancer)
12/28/2000
- "In tumor models ZK 230211 exhibited strong antiproliferative action. "
Order ALL the reference details at left... |
| 1. | Hormone Replacement Therapy (Therapy, Hormone Replacement)
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |